Neoplastic transformation induced by the gep oncogenes involves the scaffold protein JNK-interacting leucine zipper protein

Neoplasia

Volumn 13, Issue 4, 2011, Pages 358-364

  Kashef, Kimia ^a   Radhakrishnan, Rangasudhagar ^b   Lee, Clement M ^c   Reddy, E Premkumar ^c   Dhanasekaran, Danny N ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; LEUCINE ZIPPER PROTEIN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INTERACTING LEUCINE ZIPPER PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL STRAIN 3T3; CELL STRAIN COS7; CONTROLLED STUDY; ENZYME ACTIVATION; GENE MUTATION; GEP GENE; MALIGNANT TRANSFORMATION; ONCOGENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 79953674832     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.101622     Document Type: Article

References (35)

1. Gutkind JS, Coso OA, and Xu N (1998). Gα12-and Gα13-subunits of heterotrimeric G proteins: a novel family of oncogenes. In G Proteins, Receptors, and Diseases. S Spiegel (Ed). Humana Press, Totowa, NJ. pp. 101-117.
2. Radhika Vand Dhanasekaran N (2001). Transforming G proteins. Oncogene 20, 1607-1614.
3. Prasad MV, Dermott JM, Heasley LE, Johnson GL, and Dhanasekaran N (1995). Activation of Jun kinase/stress-activated protein kinase by GTPase-deficient mutants of Gα12 and Gα13. J Biol Chem 270, 18655-18659.
4. Voyno-Yasenetskaya TA, Faure MP, Ahn NG, and Bourne HR (1996). Gα12 and Gα13 regulate extracellular signal-regulated kinase and c-Jun kinase pathways by different mechanisms in COS-7 cells. J Biol Chem 271, 21081-21087.
5. Collins LR, Minden A, Karin M, and Brown JH (1996). Gα12 stimulates c-Jun NH2-terminal kinase through the small G proteins Ras and Rac. J Biol Chem 271, 17349-17353.
6. Mitsui H, Takuwa N, Kurokawa K, Exton JH, and Takuwa Y (1997). Dependence of activated Gα12-induced G1 to S phase cell cycle progression on both Ras/ mitogen-activated protein kinase and Ras/Rac1/Jun N-terminal kinase cascades in NIH3T3 fibroblasts. J Biol Chem 272, 4904-4910.
7. Berestetskaya YV, Faure MP, Ichijo H, and Voyno-Yasenetskaya TA (1998). Regulation of apoptosis by α-subunits of G12 and G13 proteins via apoptosis signalregulating kinase 1. J Biol Chem 273, 27816-28723.
8. Kumar RN, Radhakrishnan R, Ha JH, and Dhanasekaran N (2004). Proteome analysis of NIH3T3 cells transformed by activated Gα12: regulation of leukemiaassociated protein SET. J Proteome Res 3, 1177-1183.
9. Kumar RN, Ha JH, Radhakrishnan R, and Dhanasekaran DN (2006). Transactivation of platelet-derived growth factor receptor alpha by the GTPase-deficient activated mutant of Gα12. Mol Cell Biol 26, 50-62.
10. Radhakrishnan R, Ha JH, and Dhanasekaran DN (2010). Mitogenic signaling by the gep oncogene involves the upregulation of S-phase kinase-associated protein 2. Genes Cancer 1, 1033-1043.
11. Jho EH, Davis RJ, and Malbon CC (1997). c-Jun amino-terminal kinase is regulated by Gα12/Gα13 and obligate for differentiation of P19 embryonal carcinoma cells by retinoic acid. J Biol Chem 272, 24468-24474.
12. Kashef K, Lee CM, Ha JH, Reddy EP, and Dhanasekaran DN (2005). JNKinteracting leucine zipper protein is a novel scaffolding protein in the Gα13 signaling pathway. Biochem 44, 14090-14096.
13. Radhika V, Ha JH, Jayaraman M, Tsim ST, and Dhanasekaran N (2005). Mitogenic signaling by lysophosphatidic acid (LPA) involves Gα12. Oncogene 24, 4597-4603.
14. Marinissen MJ, Servitja JM, Offermanns S, Simon MI, and Gutkind JS (2003). Thrombin protease activated receptor-1 signals though Gq and G13-initiatedMAPK cascades regulating c-Jun expression to induce cell transformation. J Biol Chem 278, 46814-46825.
15. Radhika V, Onesime D, Ha JH, and Dhanasekaran N (2004). Gα13 stimulates cell migration through cortactin-interacting protein Hax-1. J Biol Chem 279, 49406-49413.
16. Yuan J, Slice LW, and Rozengurt E (2003). Cooperation of Gq, Gi, and G12/13 in protein kinase D activation and phosphorylation induced by lysophosphatidic acid. J Biol Chem 278, 4882-4891.
17. Lee CL, Onesime D, Reddy CD, Dhanasekaran N, and Reddy EP (2000). JLP: a scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors. Proc Natl Acad Sci USA 99, 14189-14194.
18. Nguyen Q, Lee CM, and Reddy EP (2005). JLP associates with kinesin light chain 1 through a novel leucine zipper-like domain. J Biol Chem 280, 30185-30191.
19. Xu H, Dhanasekaran DN, Lee CM, and Reddy EP (2010). Regulation of neurite outgrowth by interactions between the scaffolding protein, JNK-associated leucine zipper protein, and neuronal growth-associated protein superior cervical ganglia clone 10. J Biol Chem 285, 3548-3553.
20. Cox AD and Der CJ (1994). Biological assays for cellular transformation. Methods Enzymol 238, 277-294.
21. Chan AM, Fleming TP, McGovern ES, Chedid M, Miki T, and Aaronson SA (1993). Expression cDNA cloning of a transforming gene encoding the wild-type Gα12 gene product. Mol Cell Biol 13, 762-768.
22. Xu N, Ambudkar I, and Gutkind JS (1994). A mutant α subunit of G12 potentiates the eicosanoid pathway and is highly oncogenic in NIH3T3 cells. Proc Natl Acad Sci USA 90, 6741-6745.
23. Vara Prasad MV, Shore SK, and Dhanasekaran N (1994). Activated mutant of Gα13 induces Egr-1, c-fos, and transformation in NIH 3T3 cells. Oncogene 9, 2425-2429.
24. Voyno-Yasenetskaya TA, Pace AM, and Bourne HR (1994). Mutant a subunits of G12 and G13 proteins induce neoplastic transformation of Rat-1 fibroblasts. Oncogene 9, 2559-2565.
25. Dermott JM, Ha J, Lee C, and Dhanasekaran N (2004). Differential regulation of Jun N-terminal kinase and p38MAP kinase by Gα12. Oncogene 23, 226-232.
26. Kashef K, Xu H, Reddy EP, and Dhanasekaran DN (2006). Endodermal differentiation of murine embryonic carcinoma cells by retinoic acid requires JLP, a JNK-scaffolding protein. J Cell Biochem 98, 715-722.
27. Andersson J, Simpson DM, Qi M, Wang Y, and Elion EA (2004). Differential input by Ste5 scaffold and Msg5 phosphatase route a MAPK cascade to multiple outcomes. EMBO J 23, 2564-2576.
28. Elion EA, Qi M, and Chen W (2005). Signal transduction. Signaling specificity in yeast. Science 307, 687-688.
29. Dhanasekaran DN, Kashef K, Lee CM, Xu H, and Reddy EP (2007). Scaffold proteins of MAP-kinase modules. Oncogene 26, 3185-3202.
30. Elion EA (2001). Ste5: a meeting place for MAP kinases and their associates. J Cell Sci 114, 3967-3978.
31. Schwartz MA and Madhani HD (2004). Principles of MAP kinase signaling specificity in Saccharomyces cerevisiae. Annu Rev Genet 38, 725-748.
32. Daaka Y (2002). Mitogenic action of LPA in prostate. Biochim Biophys Acta 1582, 265-269.
33. Yamada T, Sato K, Komachi M, Malchinkhuu E, Tobo M, Kimura T, Kuwabara A, Yanagita Y, Ikeya T, Tanahashi Y, et al. (2004). Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. J Biol Chem 279, 6595-6605.
34. Kishi Y, Okudaira S, Tanaka M, Hama K, Shida D, Kitayama J, Yamori T, Aoki J, Fujimaki T, and Arai H (2006). Autotaxin is overexpressed in glioblastoma multiforme and contributes to cellmotility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J Biol Chem 281, 17492-17500.
35. Panupinthu N, Lee HY, and Mills GB (2010). Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression. Br J Cancer 102, 941-946.